Thanaa E A Helal

Summary

Publications

  1. ncbi Role of alpha methylacyl-coenzyme A racemase in differentiating hepatocellular carcinoma from dysplastic and nondysplastic liver cell lesions
    Thanaa El A Helal
    Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    Ann Diagn Pathol 16:330-4. 2012
  2. ncbi Immunoexpression of p53 and hMSH2 in oral squamous cell carcinoma and oral dysplastic lesions in Yemen: relationship to oral risk habits and prognostic factors
    Thanaa El A Helal
    Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    Oral Oncol 48:120-4. 2012
  3. ncbi Immunophenotyping of tumor-infiltrating mononuclear cells in ovarian carcinoma
    Thanaa El A Helal
    Department of Pathology, Ain Shams Faculty of Medicine, Cairo, Egypt
    Pathol Oncol Res 10:80-4. 2004
  4. ncbi Lymphocytic colitis: a clue to bacterial etiology
    Thanaa Ea Helal
    Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    World J Gastroenterol 11:7266-71. 2005
  5. ncbi Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors
    Thanaa El A Helal
    Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    Pathol Oncol Res 12:173-8. 2006
  6. ncbi Immunohistochemical expression of mismatch repair genes (hMSH2 and hMLH1) in hepatocellular carcinoma in Egypt
    Thanaa E A Helal
    Department of Pathology, Ain Shams University, Cairo, Egypt
    APMIS 118:934-40. 2010

Collaborators

Detail Information

Publications6

  1. ncbi Role of alpha methylacyl-coenzyme A racemase in differentiating hepatocellular carcinoma from dysplastic and nondysplastic liver cell lesions
    Thanaa El A Helal
    Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    Ann Diagn Pathol 16:330-4. 2012
    ..Alpha methylacyl-COA racemase cannot discriminate HCC from LCD, although it can separate HCC and LCD from nondysplastic lesions...
  2. ncbi Immunoexpression of p53 and hMSH2 in oral squamous cell carcinoma and oral dysplastic lesions in Yemen: relationship to oral risk habits and prognostic factors
    Thanaa El A Helal
    Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    Oral Oncol 48:120-4. 2012
    ..Such a relationship has not been published previously in this type of cancer and needs to be clarified in future studies...
  3. ncbi Immunophenotyping of tumor-infiltrating mononuclear cells in ovarian carcinoma
    Thanaa El A Helal
    Department of Pathology, Ain Shams Faculty of Medicine, Cairo, Egypt
    Pathol Oncol Res 10:80-4. 2004
    ..0005). CD8+ T cells and macrophages constitute a major component of the infiltrating mononuclear cells in ovarian carcinoma. Their frequency seems to be related to the tumor type rather than the degree of tumor differentiation...
  4. ncbi Lymphocytic colitis: a clue to bacterial etiology
    Thanaa Ea Helal
    Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    World J Gastroenterol 11:7266-71. 2005
    ..To find out the role of bacteria as a possible etiological factor in lymphocytic colitis...
  5. ncbi Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors
    Thanaa El A Helal
    Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    Pathol Oncol Res 12:173-8. 2006
    ..More importantly, HPV does not seem to play a role in the pathogenesis of either type of bladder cancer in our country...
  6. ncbi Immunohistochemical expression of mismatch repair genes (hMSH2 and hMLH1) in hepatocellular carcinoma in Egypt
    Thanaa E A Helal
    Department of Pathology, Ain Shams University, Cairo, Egypt
    APMIS 118:934-40. 2010
    ..Moreover, the significant association between reduced expression of both MMR genes and poor histologic grades of the tumor claims that these proteins are involved in the process of cancer progression...